Deciphera Pharmaceuticals, Inc. Marketable Securities
Deciphera Pharmaceuticals, Inc. had Marketable Securities of $181.30 million as of 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2024-05-10
- 2024-03-31: Marketable Securities $181.30M.
- 2023-12-31: Marketable Securities $222.71M.
- 2023-09-30: Marketable Securities $230.99M.
- 2023-06-30: Marketable Securities $247.35M.
| Period end | Marketable Securities |
|---|---|
| 2024-03-31 | $181.30M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $222.71M 10-Q · filed 2024-05-10 |
| 2023-09-30 | $230.99M 10-Q · filed 2023-10-30 |
| 2023-06-30 | $247.35M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $284.00M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $259.75M 10-Q · filed 2023-10-30 |
| 2022-09-30 | $282.04M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $274.15M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $161.22M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $198.57M 10-K · filed 2023-02-07 |
| 2021-09-30 | $289.08M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $304.40M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $300.53M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $416.03M 10-K · filed 2022-02-08 |
| 2020-09-30 | $434.17M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $454.89M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $461.85M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $459.26M 10-K · filed 2021-02-09 |
| 2019-09-30 | $460.88M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $168.18M 10-Q · filed 2019-08-02 |
| 2019-03-31 | $180.11M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-09 |